N
XBIT icon

Nuveen’s XBiotech XBIT Stock Holding History

Nuveen’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,879
Closed -$80.6K – 3425
2025
Q1 		$80.6K Hold
24,879
– – ﹤0.01% 3233
2024
Q4 		$98.3K Hold
24,879
– – ﹤0.01% 3290
2024
Q3 		$192K Hold
24,879
– – ﹤0.01% 3231
2024
Q2 		$128K Buy
+24,879
New +$192K ﹤0.01% 3288
2022
Q2 		– Sell
-88,400
Closed -$764K – 3503
2022
Q1 		$764K Buy
88,400
+2,438
+3% +$24.5K ﹤0.01% 2901
2021
Q4 		$957K Buy
85,962
+15,546
+22% +$202K ﹤0.01% 2874
2021
Q3 		$912K Sell
70,416
-35,333
-33% -$563K ﹤0.01% 3018
2021
Q2 		$448K Buy
105,749
+31,624
+43% +$536K ﹤0.01% 3177
2021
Q1 		$1.15M Sell
74,125
-8,430
-10% -$157K ﹤0.01% 2844
2020
Q4 		$1.29M Buy
82,555
+7,460
+10% +$137K ﹤0.01% 2711
2020
Q3 		$1.43M Buy
75,095
+8,082
+12% +$139K ﹤0.01% 2516
2020
Q2 		$918K Buy
67,013
+5,585
+9% +$78.5K ﹤0.01% 2651
2020
Q1 		$652K Sell
61,428
-11,794
-16% -$192K ﹤0.01% 2680
2019
Q4 		$1.37M Buy
73,222
+15,547
+27% +$200K ﹤0.01% 2579
2019
Q3 		$634K Buy
57,675
+14,434
+33% +$118K ﹤0.01% 2875
2019
Q2 		$328K Buy
+43,241
New +$376K ﹤0.01% 3108

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's XBIT Position: Q2 2025 in Review

Nuveen sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 24,879 shares — an estimated $80.6K sold.

Nuveen first reported a position in XBIT in Q2 2019 and held it in 16 quarters. The position peaked at $1.43M in Q3 2020. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Nuveen reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 24,879 XBiotech shares in Q2 2025, an estimated $80.6K.
  • Nuveen first reported a position in XBiotech in Q2 2019 and held it in 16 quarters.
  • Nuveen's XBiotech position peaked at $1.43M in Q3 2020.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.